Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Gallium maltolate is a promising chemotherapeutic agent for the treatment of hepatocellular carcinoma.

Chua MS, Bernstein LR, Li R, So SK.

Anticancer Res. 2006 May-Jun;26(3A):1739-43.

2.

Hepatocellular carcinoma detection by gallium scan and subsequent treatment by gallium maltolate: rationale and case study.

Bernstein LR, van der Hoeven JJ, Boer RO.

Anticancer Agents Med Chem. 2011 Jul;11(6):585-90.

PMID:
21554205
3.
4.

Comparison of the antimicrobial activities of gallium nitrate and gallium maltolate against Mycobacterium avium subsp. paratuberculosis in vitro.

Fecteau ME, Aceto HW, Bernstein LR, Sweeney RW.

Vet J. 2014 Oct;202(1):195-7. doi: 10.1016/j.tvjl.2014.06.023. Epub 2014 Jul 3.

PMID:
25155307
5.

Gallium maltolate inhibits human cutaneous T-cell lymphoma tumor development in mice.

Wu X, Wang TW, Lessmann GM, Saleh J, Liu X, Chitambar CR, Hwang ST.

J Invest Dermatol. 2015 Mar;135(3):877-884. doi: 10.1038/jid.2014.476. Epub 2014 Nov 5.

6.

Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction.

Schulze-Bergkamen H, Fleischer B, Schuchmann M, Weber A, Weinmann A, Krammer PH, Galle PR.

BMC Cancer. 2006 Oct 2;6:232.

7.

Kurarinol induces hepatocellular carcinoma cell apoptosis through suppressing cellular signal transducer and activator of transcription 3 signaling.

Shu G, Yang J, Zhao W, Xu C, Hong Z, Mei Z, Yang X.

Toxicol Appl Pharmacol. 2014 Dec 1;281(2):157-65. doi: 10.1016/j.taap.2014.06.021. Epub 2014 Jul 2.

PMID:
24997323
8.

A novel gallium compound synergistically enhances bortezomib-induced apoptosis in mantle cell lymphoma cells.

Chitambar CR, Purpi DP.

Leuk Res. 2010 Jul;34(7):950-3. doi: 10.1016/j.leukres.2010.02.034. Epub 2010 Mar 24.

9.

Serum and tissue concentrations of gallium after oral administration of gallium nitrate and gallium maltolate to neonatal calves.

Monk CS, Sweeney RW, Bernstein LR, Fecteau ME.

Am J Vet Res. 2016 Feb;77(2):151-5. doi: 10.2460/ajvr.77.2.151.

PMID:
27027708
10.

Growth inhibition by NVP-BEZ235, a dual PI3K/mTOR inhibitor, in hepatocellular carcinoma cell lines.

Masuda M, Shimomura M, Kobayashi K, Kojima S, Nakatsura T.

Oncol Rep. 2011 Nov;26(5):1273-9. doi: 10.3892/or.2011.1370. Epub 2011 Jul 1.

PMID:
21725613
11.

Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells.

Wu Q, Qin SK, Teng FM, Chen CJ, Wang R.

J Hematol Oncol. 2010 Oct 31;3:43. doi: 10.1186/1756-8722-3-43.

12.

Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model.

Wang C, Gao D, Guo K, Kang X, Jiang K, Sun C, Li Y, Sun L, Shu H, Jin G, Sun H, Wu W, Liu Y.

BMC Cancer. 2012 May 4;12:166. doi: 10.1186/1471-2407-12-166.

13.

Allele-specific imbalance of oxidative stress-induced growth inhibitor 1 associates with progression of hepatocellular carcinoma.

Liu M, Li Y, Chen L, Chan TH, Song Y, Fu L, Zeng TT, Dai YD, Zhu YH, Li Y, Chen J, Yuan YF, Guan XY.

Gastroenterology. 2014 Apr;146(4):1084-96. doi: 10.1053/j.gastro.2013.12.041. Epub 2014 Jan 11.

PMID:
24417816
14.

Antibody against granulin-epithelin precursor sensitizes hepatocellular carcinoma to chemotherapeutic agents.

Wong NC, Cheung PF, Yip CW, Chan KF, Ng IO, Fan ST, Cheung ST.

Mol Cancer Ther. 2014 Dec;13(12):3001-12. doi: 10.1158/1535-7163.MCT-14-0012. Epub 2014 Sep 24.

15.

Synergistic effects of IAP inhibitor LCL161 and paclitaxel on hepatocellular carcinoma cells.

Tian A, Wilson GS, Lie S, Wu G, Hu Z, Hebbard L, Duan W, George J, Qiao L.

Cancer Lett. 2014 Sep 1;351(2):232-41. doi: 10.1016/j.canlet.2014.06.006. Epub 2014 Jun 27.

PMID:
24976294
16.

In vitro susceptibility of equine-obtained isolates of Corynebacterium pseudotuberculosis to gallium maltolate and 20 other antimicrobial agents.

Norman TE, Batista M, Lawhon SD, Zhang S, Kuskie KR, Swinford AK, Bernstein LR, Cohen ND.

J Clin Microbiol. 2014 Jul;52(7):2684-5. doi: 10.1128/JCM.01252-14. Epub 2014 May 14.

17.

TRAIL-induced apoptosis of hepatocellular carcinoma cells is augmented by targeted therapies.

Koehler BC, Urbanik T, Vick B, Boger RJ, Heeger S, Galle PR, Schuchmann M, Schulze-Bergkamen H.

World J Gastroenterol. 2009 Dec 21;15(47):5924-35.

18.

Antitumor activity of acriflavine in human hepatocellular carcinoma cells.

Lee CJ, Yue CH, Lin YY, Wu JC, Liu JY.

Anticancer Res. 2014 Jul;34(7):3549-56.

PMID:
24982368
19.

Bid sensitizes apoptosis induced by chemotherapeutic drugs in hepatocellular carcinoma.

Miao J, Chen GG, Chun SY, Chak EC, Lai PB.

Int J Oncol. 2004 Sep;25(3):651-9.

PMID:
15289866
20.

Growth inhibition and apoptosis induced by osthole, a natural coumarin, in hepatocellular carcinoma.

Zhang L, Jiang G, Yao F, He Y, Liang G, Zhang Y, Hu B, Wu Y, Li Y, Liu H.

PLoS One. 2012;7(5):e37865. doi: 10.1371/journal.pone.0037865. Epub 2012 May 25.

Supplemental Content

Support Center